Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Growth Potential of the Monkey Pox Testing Market Size Over 2025-2034?
The monkey pox testing market size has grown steadily in recent years. It will grow from $1.46 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increasing government funding and initiatives, increasing demand to provide rapid tests, increasing testing capacity, increasing research and development, and increasing public awareness campaigns.
The monkey pox testing market size is expected to see steady growth in the next few years. It will grow to " $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to rising healthcare expenditures, development of point-of-care (POC) tests, growth in at-home testing kits, focus on accessibility and affordability, and healthcare infrastructure improvement. Major trends in the forecast period include integration of testing with surveillance systems, integration with digital health tools, technological advancements, integration into public health systems and advancements in diagnostic research.
Get your free report sample today:
What Are the Primary Factors Driving the Monkey Pox Testing Market?
The increasing incidence of monkey pox disease is expected to propel the growth of the monkey pox testing market going forward. Monkeypox is a rare viral disease caused by the monkeypox virus, a member of the orthodox virus genus related to the smallpox virus. The rise in monkeypox cases is due to increased human-to-human transmission, global travel, and reduced immunity from discontinued smallpox vaccination programs. Monkeypox testing helps by identifying infected individuals early, allowing for timely treatment and isolation to prevent further spread of the disease. It also aids in tracking outbreaks and understanding the virus's transmission patterns. For instance, in May 2022, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, from January to April 2022, there were 1,152 suspected monkeypox cases, leading to 55 deaths and a case-fatality rate of 4.8%, spread across 54 health zones in 14 provinces. Further, in comparison to the same period in 2021, there is an increase of 138 suspected cases and 14 deaths, resulting in a higher case-fatality rate of 10.1%. Therefore, the increasing incidence of monkey pox disease is driving the growth of the monkey pox testing market.
Which Segments Are Likely to Shape the Future Outlook of the Monkey Pox Testing Market?
The monkey pox testingmarket covered in this report is segmented –
1) By Technology: Polymerase Chain Reaction (PCR); Lateral Flow Assay (LFA); Other Technologies
2) By Mode: Laboratory Testing; Point Of Care Testing
3) By End-Use: Hospitals And Clinics; Diagnostic Laboratories; Other End-Uses
Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR); Reverse Transcription PCR (RT-PCR); Multiplex PCR
2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays; Rapid Antigen Detection Kits
3) By Other Technologies: ELISA (Enzyme-Linked Immunosorbent Assay); CRISPR-based Testing; Serological Tests (Antibody Detection); Nucleic Acid Sequence-Based Amplification (NASBA)
Which Disruptive Trends Are Reshaping the Competitive Landscape of the Monkey Pox Testing Market?
Major companies operating in the monkey pox testing market are focusing on developing advanced diagnostic solutions, such as saliva-based monkey pox testing, to enhance accuracy, convenience, and accessibility. Saliva-based monkey pox testing is a diagnostic method that uses saliva samples to detect the presence of the monkeypox virus. For instance, in July 2022, Flow Health, a US-based medical laboratory, launched the saliva-based (polymerase chain reaction) PCR test for monkeypox, revolutionizing the testing process by offering a more convenient and non-invasive method for virus detection. This innovative test stands out with its high sensitivity and specificity, rapid genetic material amplification, and versatility for various applications. It allows for quantitative analysis of viral loads and direct pathogen detection, all while simplifying sample collection. One of its key advantages is the ability to test individuals before visible lesions appear, which is crucial for early detection and reducing virus transmission.
Which Key Players Dominate the Monkey Pox Testing Market Landscape?
Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.
Get the detailed monkey pox testing market report today
Which Region Is Expected to Dominate the Monkey Pox Testing Market During the Forecast Period?
North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment